tiprankstipranks
Advertisement
Advertisement

SPRY Stock Latest News

Analyst Maintains Buy on ARS Pharmaceuticals as Neffy Access Prospects and Commercial Execution Improve
RatingsAnalyst Maintains Buy on ARS Pharmaceuticals as Neffy Access Prospects and Commercial Execution Improve
3d ago
SPRY
ARS Pharmaceuticals price target raised to $30 from $12 at Cantor Fitzgerald
PremiumThe Fly
ARS Pharmaceuticals price target raised to $30 from $12 at Cantor Fitzgerald
7d ago
SPRY
Ars Pharmaceuticals’ Earnings Call Highlights Growth and Risks
PremiumCompany Announcements
Ars Pharmaceuticals’ Earnings Call Highlights Growth and Risks
16d ago
SPRY
Third Point buys Meta, exits PG&E in Q1
PremiumThe Fly
Third Point buys Meta, exits PG&E in Q1
20d ago
BAM
COF
Midday Fly By: Applied Materials, Figma post ‘beat and raise’ reports
PremiumThe Fly
Midday Fly By: Applied Materials, Figma post ‘beat and raise’ reports
20d ago
BX
DLO
Morning Movers: Cerebras Systems pulls back after smash IPO
PremiumThe FlyMorning Movers: Cerebras Systems pulls back after smash IPO
20d ago
FIG
RBC
Options Volatility and Implied Earnings Moves Today, May 15, 2026
Premium
Market News
Options Volatility and Implied Earnings Moves Today, May 15, 2026
20d ago
DSX
RBC
ARS Pharmaceuticals Highlights Strong Neffy Growth and Global Expansion
Premium
Company Announcements
ARS Pharmaceuticals Highlights Strong Neffy Growth and Global Expansion
20d ago
8K
SPRY
ARS Pharmaceuticals reports Q1 EPS (61c), consensus (54c)
PremiumThe Fly
ARS Pharmaceuticals reports Q1 EPS (61c), consensus (54c)
20d ago
SPRY
ARS Pharmaceuticals Appoints Donn Casale as New President
PremiumCompany Announcements
ARS Pharmaceuticals Appoints Donn Casale as New President
22d ago
8K
SPRY
ARS Pharmaceuticals announces Health Canada approval of neffy 2 mg
PremiumThe Fly
ARS Pharmaceuticals announces Health Canada approval of neffy 2 mg
2M ago
SPRY
ARS Pharmaceuticals initiated with an Outperform at Northland
PremiumThe Fly
ARS Pharmaceuticals initiated with an Outperform at Northland
2M ago
SPRY
Northland starts disruptor ARS Pharmaceuticals with an Outperform
PremiumThe FlyNorthland starts disruptor ARS Pharmaceuticals with an Outperform
2M ago
SPRY
Ars Pharmaceuticals Earnings Call Highlights Neffy’s Early Traction
Premium
Company Announcements
Ars Pharmaceuticals Earnings Call Highlights Neffy’s Early Traction
2M ago
SPRY
ARS Pharmaceuticals receives FDA approval to remove neffy 1 mg age requirement
Premium
The Fly
ARS Pharmaceuticals receives FDA approval to remove neffy 1 mg age requirement
2M ago
SPRY
Nasus Pharma’s Positive Phase 2 Data Validates the Speed and Reliability of the NS002 Powder Platform
PremiumTipRanks Newswire
Nasus Pharma’s Positive Phase 2 Data Validates the Speed and Reliability of the NS002 Powder Platform
3M ago
CTMX
NSRX
Midday Fly By: Hims & Hers reaches Novo deal, Live Nation settles with DOJ
PremiumThe Fly
Midday Fly By: Hims & Hers reaches Novo deal, Live Nation settles with DOJ
3M ago
MU
VZ
ARS Pharmaceuticals Reports 2025 Results and neffy Growth
PremiumCompany Announcements
ARS Pharmaceuticals Reports 2025 Results and neffy Growth
3M ago
8K
SPRY
ARS Pharmaceuticals reports Q4 EPS (42c), consensus (44c)
PremiumThe Fly
ARS Pharmaceuticals reports Q4 EPS (42c), consensus (44c)
3M ago
SPRY
ARS Pharmaceuticals announces CHMP of EMA adopted positive opinion for EURneffy
PremiumThe FlyARS Pharmaceuticals announces CHMP of EMA adopted positive opinion for EURneffy
4M ago
SPRY
ARS Pharmaceuticals announces California eligible for neffyinSchools program
Premium
The Fly
ARS Pharmaceuticals announces California eligible for neffyinSchools program
4M ago
SPRY
ARS Pharmaceuticals: Buy Rating Reaffirmed on Improved Competitive Outlook After Aquestive’s Anaphylm Setback
Premium
Ratings
ARS Pharmaceuticals: Buy Rating Reaffirmed on Improved Competitive Outlook After Aquestive’s Anaphylm Setback
5M ago
SPRY

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >